Understanding Kidney Signals for Blood Pressure Control
Significance of Epac signaling in renal Na+handling and hypertension
This research explores how specific signals in the kidneys affect salt balance to discover new ways to help people with high blood pressure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11169848 on NIH RePORTER |
What this research studies
Our kidneys play a vital role in managing the body's salt and water levels, and retaining too much salt is often linked to high blood pressure. Current medications called diuretics help by blocking salt reabsorption in certain parts of the kidney, but other parts can sometimes compensate, limiting their effectiveness. This project focuses on special proteins called Epac in the kidneys, which appear to control salt handling in multiple kidney areas at once. By understanding how Epac works, we hope to develop new medications that can more effectively target salt retention and help manage high blood pressure.
Who could benefit from this research
Good fit: Patients with high blood pressure, especially those whose condition is related to how their kidneys handle salt, might eventually benefit from the discoveries made in this research.
Not a fit: Patients whose high blood pressure is not primarily linked to kidney salt retention or the Epac signaling pathway may not directly benefit from this specific therapeutic approach.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, more effective medications for high blood pressure that work differently than existing treatments.
How similar studies have performed: Early findings in animal models suggest that targeting Epac proteins can influence blood pressure, and this work aims to develop new medications based on these promising insights.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Pochynyuk, Oleh — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Pochynyuk, Oleh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.